Rice lab to help develop bioprinted kidneys as part of ARPA-H PRINT program award
Rice bioengineer Antonios Mikos is part of a team of researchers led by the Wake Forest Institute for Regenerative Medicine awarded up to $24.8 million over five years to help address the nation’s growing organ donor shortage by bioprinting on-demand kidney tissues.
Rice bioengineers developed a new genetic regulatory system that makes the production of gas vesicles more sustainable for nonnative host cells.
Rice remembers Larry McIntire, founder of bioengineering at Rice and ‘guiding force’ in the field
Rice remembers Larry McIntire, founder of bioengineering at Rice and ‘guiding force’ in biomedical engineering.
Rice's SynthX Center has received an up to five-year, $18 million award from the Advanced Research Projects Agency for Health.
Rice bioengineers explore new gene delivery systems with Keck Foundation support
Rice bioengineers Gang Bao and Caleb Bashor are leading a project focused on exploring how biological systems derived from nature can be engineered to deliver long-form genetic instructions for the expression of critical proteins and genome modification to target tissues in living organisms.
Scientists demonstrate first-time use of AI for genetic circuit design
A new study reports first-time use of artificial intelligence for genetic circuit design.
Rice Brain Institute awards first seed grants to jump-start collaborative brain health research
The Rice Brain Institute has announced the awardees of its first funding initiative, a seed grant program that is a collaborative effort between the university and four institutional partners in the Texas Medical Center.
Rice-led biotech symposium highlights collaboration at Texas Medical Center research hub
Researchers from Rice, Baylor College of Medicine and Houston Methodist gathered in the Texas Medical Center’s Helix Park for the inaugural Biotech Innovation Symposium, an event designed to strengthen research collaborations among researchers and clinicians who can draw on the shared research infrastructure of the Dynamic One building.
WHO newborn health leader calls for resilient, equity-driven global health systems at Rice360 event
Queen Dube, Newborn Health Program lead at the World Health Organization, delivered the third and final lecture in the Rice360 Institute for Global Health Technologies Seminar Series Dec. 3, offering a global perspective on the future of newborn health and the urgent need to rethink how care systems are designed and delivered worldwide.
Innovation across Africa takes center stage at Rice360’s first networkwide design competition
The Rice360 Institute for Global Health Technologies and its invention education partners across Africa marked a major milestone at the first Invention Education Networkwide Design Competition, a two-day event held Nov. 20-21 that brought together the most promising student-led innovations from seven university design studios across the continent.
New study identifies affordable, accurate tools to detect low blood sugar in newborns globally
A new study led by researchers at Rice360 Institute for Global Health Technologies evaluated the accuracy and reliability of 11 commonly available point-of-care glucometers to determine which could safely be adapted for neonatal care in resource-constrained settings.
Materials that match the brain: Rice engineer earns Sontag Foundation distinction
Rice materials scientist and neuroengineer Christina Tringides has been named a Distinguished Scientist by the Sontag Foundation, a national recognition for early career researchers advancing transformative projects in brain cancer research.
A molecular ‘reset button’ for reading the brain through a blood test
Rice bioengineers have designed an erasable serum marker that could enable clinicians to detect problems or measure any changes in how a patient responds to treatment with greater precision, using simple, minimally-invasive testing.
How AI can help detect disease and accelerate medical breakthroughs
As artificial intelligence plays an increasingly prominent role in decoding DNA, tracking pathogens and accelerating drug discovery, the line between real capability and hype can be unclear. Rice experts can provide clear, technically grounded perspectives on how these tools are meaningfully advancing disease detection, public health preparedness and treatment design.
Nonsurgical treatment shows promise for targeted seizure control
Rice bioengineers have demonstrated a nonsurgical way to quiet a seizure-relevant brain circuit using a method that merges ultrasound, gene therapy and chemogenetics.
